Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Hamilton

Showing results (171-180 of 186) with videos related to

Pageof 19
Sort By:
Journal of Cardiovascular Pharmacology|July 1, 1997
Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogsA A Parsons, S G Parker, P Raval, et al.
Journal of the National Cancer Institute|December 18, 1996
Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomiesH Salazar, A K Godwin, M B Daly, et al.
Cancer Research|March 1, 1987
Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancerD J FitzGerald, M J Bjorn, R J Ferris, et al.
Cancer Research|February 1, 1994
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 scheduleR J Schilder, F P LaCreta, R P Perez, et al.
The Journal of Biological Chemistry|September 29, 2001
Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cellsE R Smith, C D Capo-chichi, J He, et al.
Stroke|November 1, 1995
Failure of isradipine to reduce infarct size in mouse, gerbil, and rat models of cerebral ischemiaS J Bailey, N I Wood, N A Samson, et al.
Cancer Research|November 1, 1988
Genes amplified and overexpressed in human multidrug-resistant cell linesA M Van der Bliek, F Baas, T Van der Velde-Koerts, et al.
Biochemical Pharmacology|July 15, 1985
Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionT C Hamilton, M A Winker, K G Louie, et al.
Cancer Research|January 15, 1987
Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analoguesB C Behrens, T C Hamilton, H Masuda, et al.
Biochemical Pharmacology|February 1, 1986
Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell linesK G Louie, T C Hamilton, M A Winker, et al.
Pageof 19

Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Journal of Cardiovascular Pharmacology|July 1, 1997
Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogsA A Parsons, S G Parker, P Raval, et al.
Journal of the National Cancer Institute|December 18, 1996
Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomiesH Salazar, A K Godwin, M B Daly, et al.
Cancer Research|March 1, 1987
Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancerD J FitzGerald, M J Bjorn, R J Ferris, et al.
Cancer Research|February 1, 1994
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 scheduleR J Schilder, F P LaCreta, R P Perez, et al.
The Journal of Biological Chemistry|September 29, 2001
Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cellsE R Smith, C D Capo-chichi, J He, et al.
Stroke|November 1, 1995
Failure of isradipine to reduce infarct size in mouse, gerbil, and rat models of cerebral ischemiaS J Bailey, N I Wood, N A Samson, et al.
Cancer Research|November 1, 1988
Genes amplified and overexpressed in human multidrug-resistant cell linesA M Van der Bliek, F Baas, T Van der Velde-Koerts, et al.
Biochemical Pharmacology|July 15, 1985
Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionT C Hamilton, M A Winker, K G Louie, et al.
Cancer Research|January 15, 1987
Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analoguesB C Behrens, T C Hamilton, H Masuda, et al.
Biochemical Pharmacology|February 1, 1986
Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell linesK G Louie, T C Hamilton, M A Winker, et al.
Pageof 19